Ligand profile
69J
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_05433 — Enoyl-[acyl-carrier-protein] reductase [NADH]
Identifiers
Database identifiers and provenance.
- Ligand ID
69J- PDB
5i9n- UniProt (similar protein)
A0A0H3HP34- Target protein
- KP13_05433
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 72.6
- −1 ≤ LogP ≤ 5 3.79
- MW ≤ 500 Da 277.3
- LogP ≤ 5 3.79
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 72.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCc1cc(c(cc1F)Oc2ccccc2[N+](=O)[O-])OCCc1cc(c(cc1F)Oc2ccccc2[N+](=O)[O-])O
InChI=1S/C14H12FNO4/c1-2-9-7-12(17)14(8-10(9)15)20-13-6-4-3-5-11(13)16(18)19/h3-8,17H,2H2,1H3InChI=1S/C14H12FNO4/c1-2-9-7-12(17)14(8-10(9)15)20-13-6-4-3-5-11(13)16(18)19/h3-8,17H,2H2,1H3
XQDRDJODNDLLTL-UHFFFAOYSA-NXQDRDJODNDLLTL-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 69J →
- PDB RCSB structure 5i9n →
- UniProt UniProt A0A0H3HP34 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “69J”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_05433.
PDB 16
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 60
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).